Toronto Dominion Bank
DMIIR

Toronto Dominion Bank’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Toronto Dominion Bank’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
2,696,496
+1,063,496
+65% +$121K ﹤0.01% 1566
2025
Q4 		$229K Buy
+1,633,000
New +$233K ﹤0.01% 1457

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return

Toronto Dominion Bank's DMIIR Position: Q1 2026 in Review

Toronto Dominion Bank increased its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 65% in Q1 2026, buying an estimated $121K and bringing the position to 2,696,496 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Toronto Dominion Bank first reported a position in DMIIR in Q4 2025 and has held it in 2 quarters since. The position peaked at $229K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • Toronto Dominion Bank held 2,696,496 shares of Drugs Made In America Acquisition II Corp Right worth $216K as of Q1 2026.
  • Toronto Dominion Bank bought 1,063,496 Drugs Made In America Acquisition II Corp Right shares in Q1 2026, an estimated $121K.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1566 holding.
  • Toronto Dominion Bank first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Drugs Made In America Acquisition II Corp Right position peaked at $229K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.